Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics
Source abstract
Abstract
The present study was designed to investigate the tumor-targeting potential of gemcitabine (GEM)-loaded surface-tailored chitosan (CS)/poly (ethylene glycol) nanoparticles (FA-PEG-GEM-NPs). The nanoparticles encapsulated with GEM were prepared, characterized, and tethered with folic acid. The developed formulations were characterized with respect to particle size/poly-dispersity index, shape, and zeta potential analysis. The in vitro study shows the sustained drug-release kinetics during 48 h. The present result shows remarkable cytotoxicity rendered by GEM when delivered through FA-PEG-GEM-NPs formulation. The microscopic assessment is suggestive of significant uptake of FA-PEG-GEM-NPs in comparison with the unmodified PEG-GEM-NPs and free drug. Finally, our results advocate for the sizeable compatibility, comparatively less organ toxicity, and higher anti-tumor activity of ligand-anchored and PEGylated CS nanoparticles in vitro and corroborated by in vivo investigations. In conclusion, it is interpreted that surface-tailored nanoparticles are capable to ferry bioactives selectively and specifically to tumor sites with the interception of minimal side effects, thereby suggesting their potential application in cancer therapeutics.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Respiratory Medicine, Liaocheng People’s Hospital, Liaocheng, China;
Department of Gastroenterology, Liaocheng People’s Hospital, Liaocheng, China
References (37)
Show source-provided references
1. 10.1016/S0378-5173(02)00267-310.1016/S0378-5173(02)00267-3 ↗
2. 10.1016/j.addr.2007.06.00810.1016/j.addr.2007.06.008 ↗
3. 10.1016/j.addr.2013.11.00910.1016/j.addr.2013.11.009 ↗
4. 10.1016/j.colsurfb.2015.11.03310.1016/j.colsurfb.2015.11.033 ↗
5. 10.1021/mp400269z10.1021/mp400269z ↗
6. 10.1016/j.biomaterials.2006.10.00210.1016/j.biomaterials.2006.10.002 ↗
7. 10.1016/j.lungcan.2008.03.02810.1016/j.lungcan.2008.03.028 ↗
8. Fukuda MN · Cancer Res · 2000 · 60 · 450
9. 10.1016/j.ejps.2012.09.01210.1016/j.ejps.2012.09.012 ↗
10. 10.1126/science.812824510.1126/science.8128245 ↗
11. 10.1016/j.lungcan.2008.03.01010.1016/j.lungcan.2008.03.010 ↗
12. 10.1016/j.jconrel.2010.09.00310.1016/j.jconrel.2010.09.003 ↗
13. Jain A · ActaBiomater · 2015 · 24 · 140
14. 10.1016/j.colsurfb.2015.06.02710.1016/j.colsurfb.2015.06.027 ↗
15. 10.2217/nnm.11.5310.2217/nnm.11.53 ↗
16. 10.3322/canjclin.54.1.810.3322/canjclin.54.1.8 ↗
17. 10.1186/s11671-015-1162-210.1186/s11671-015-1162-2 ↗
18. 10.1136/jcp.54.4.25710.1136/jcp.54.4.257 ↗
19. 10.1016/j.drudis.2014.12.01210.1016/j.drudis.2014.12.012 ↗
20. 10.1016/S0378-5173(02)00487-810.1016/S0378-5173(02)00487-8 ↗
21. 10.1016/j.nano.2005.06.00410.1016/j.nano.2005.06.004 ↗
22. 10.1002/jps.2308710.1002/jps.23087 ↗
23. 10.1007/s12272-014-0489-z10.1007/s12272-014-0489-z ↗
24. 10.1016/S0168-3659(01)00342-X10.1016/S0168-3659(01)00342-X ↗
25. Moghimi SM · Pharmacol Rev · 2001 · 53 · 28310.1016/S0031-6997(24)01494-7 ↗
26. 10.1016/S0928-0987(02)00257-910.1016/S0928-0987(02)00257-9 ↗
27. 10.3109/10717544.2013.86050210.3109/10717544.2013.860502 ↗
28. 10.18632/oncotarget.51910.18632/oncotarget.519 ↗
29. 10.1016/j.ijpharm.2013.07.03410.1016/j.ijpharm.2013.07.034 ↗
30. 10.1200/JCO.2000.18.1.12210.1200/JCO.2000.18.1.122 ↗
31. 10.1155/2015/86259210.1155/2015/862592 ↗
32. 10.1016/j.biomaterials.2007.05.00610.1016/j.biomaterials.2007.05.006 ↗
33. 10.1016/j.biomaterials.2013.09.00610.1016/j.biomaterials.2013.09.006 ↗
34. 10.1016/j.nano.2009.04.00110.1016/j.nano.2009.04.001 ↗
35. Yu X · Int J Nanomed · 2015 · 10 · 7045
36. 10.1016/j.biomaterials.2015.05.02710.1016/j.biomaterials.2015.05.027 ↗
37. 10.3402/nano.v3i0.1849610.3402/nano.v3i0.18496 ↗